Clinical trial
Assessment of Janus Kinase 2 Expression in Patients With Androgenic Alopecia and Its Modulation by Topical Minoxidil Therapy.
NCT07563036 is registered in ClinicalTrials.gov with Kasr El Aini Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Janus Kinase 2 Expression in Patients With Androgenic Alopecia and Its Modulation by Topical Minoxidil Therapy.
- Lead sponsor
- Kasr El Aini Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 1, 2026
- Completion date
- January 1, 2027
- Enrollment
- 25 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
androgenetic alopecia, androgenic alopecia